Chairman Michael J. Farrell - 16 Nov 2022 Form 4 Insider Report for RESMED INC (RMD)

Role: Chief Executive Officer
Signature: Michael J. Farrell, Chief Executive Officer
Issuer symbol: RMD
Transactions as of: 16 Nov 2022
Net transactions value: +$8,212,666
Form type: 4
Filing time: 18 Nov 2022, 18:55:16 UTC
Previous filing: 16 Nov 2022
Next filing: 23 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	RMD	ResMed Common Stock						3,880	16 Nov 2022	Lisette & Michael Farrell Family Foundation
holding	RMD	ResMed Common Stock						414,024	16 Nov 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RMD	ResMed Common Stock Options	Award	$8,212,666	+36,569		$224.58	36,569	16 Nov 2022	ResMed Common Stock	36,569	$224.58	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2023, 2024 and 2025.